Present status of management of nasopharyngeal carcinoma

References

• Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer incidence in five continents. IARC and 14CR5, 840–841 (1987).
   Google Scholar
• Dickson RI. Nasopharyngeal carcinoma: an eval2uation of 209 patients. Laryngoscope 91, 333–354 (1981).
   PubMed Web of Science ®Google Scholar
• Sham JST, Wei WI, Zong YS et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. Lancet 335, 371–374 (1990). Prospective study to evaluate the use of endoscopes in the detection of subclinical disease.
   Google Scholar
• Sham JST, Cheung YK, Choy D, Chan FL, Leong L. Nasopharyngeal carcinoma: CT Evaluation of patterns of tumor spread. AJNR12, 265–270(1991).
   PubMedGoogle Scholar
• Chong VFH, Fan YF, Mukherji SK. Carcinoma of the nasopharynx. Semin. Ultrasouncl CT MRI19, 449–462 (1998).
   PubMedGoogle Scholar
• Sham JST, Cheung YK, Choy D, Chan FL, Leong L. Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma. int. j Racliat. Oncol Biol. Phys. 25,787–792 (1993).
   Google Scholar
• Wei WI, Sham JST, Zong YS, Choy D, Ng MET. The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma. Cancer67, 3127–3130 (1991).
   Google Scholar
• Sham JST, Cheung YK, Choy D, Chan FL, Leong L. Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer68, 422–426 (1991).
   Google Scholar
• Chua DTT, Sham JST, Kwong DLW, Choy D, Au GKH, Wu PM. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. Cancer 78, 202–210 (1996).
   PubMed Web of Science ®Google Scholar
• Sham JST, Choy D. Prognostic value of paranasopharyngeal extension of
   Google Scholar
• •• nasopharyngeal carcinoma on local control and short-term survival. Head Neck 13, 298–310 (1991).
   Google Scholar
• Teo P, Lee WY, Yu P. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiother. Oncol 39,209–221(1996).
   Google Scholar
• Teo P, Yu P, Lee WY et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int. J Radiat. Oncol Phys. 36,291-304 (1996).
   Google Scholar
• Sham JS, Choy D, Choi PHK. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. BE J Radial 63, 108–113 (1990)
   PubMedGoogle Scholar
• Teo PM, Tsao SY, Ho JH, Yu P. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma Radiother. Oncol 21,11–23 (1991).
   Google Scholar
• Lee AW, Foo W, Law CK et al. N-staging of nasopharyngeal carcinoma: discrepancy between UICC/AJCC and Ho systems. Union Internationale Contre le Cancer, American Joint Committee for Cancer. Clin. Oncol 8,155–159 (1996).
   Google Scholar
• Manual for staging of cancer (5th Edition). American Joint Committee on Cancer; JBLippincott, Philadelphia, USA, (1997).
   Google Scholar
• Lee AW, Foo W, Law SCK et al. Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system. Int. J Cancer 84, 179–187 (1999).
   PubMed Web of Science ®Google Scholar
• •Evaluating the modified staging system.
   Google Scholar
• Cooper JS, Cohen R, Stevens RE. A comparision of staging systems for nasopharyngeal carcinoma. Cancer 83, 213–219 (1998).
   Google Scholar
• Ozyar E, Yildiz F, Akyol FH, Atahan IL. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. Int. J Radiat. Oncol Biol. Phys. 44,1079-1087 (1999).
   Google Scholar
• Heng DM, Wee J, Fong KW et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86, 1912–1920 (1999).
   PubMed Web of Science ®Google Scholar
• Ho JHC. Nasopharynx. In: Tmatrnent of Cancer Hainan KE (Ed.) Chapman and Hall, London, UK, 249–267 (1982).
   Google Scholar
• Lee AW, Sham JS, Poon YF, Ho JHC. Treatment of stage I nasopharyngeal carcinoma: analysis of the pattern of relapse and the results of withholding elective neck irradiation. Int. J Radiat. Oncol Biol. Phys. 17,1183–1190 (1989).
   PubMed Web of Science ®Google Scholar
• Perez CA, Devineni VR, Marciai-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int. J Radiat. Oncol Biol. Phys. 23,271-280 (1992).
   Google Scholar
• Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. int. I Radiat. Oncol Biol. Phys. 48 (3), 711–722 (2000).
   Google Scholar
• •Recent results in the application of 3D intensity-modulated radiotherapy.
   Google Scholar
• Chao KS, Low DA, Perez CA, Purdy JA. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience. Int.j Cancer90, 92–103 (2000).
   PubMed Web of Science ®Google Scholar
• Lee AWM, Poon YF, Foo W et al Retrospective analysis of 5037 patients with nasopharyngeal carcinoma-treated during 1975–1985, overall survival and patterns of failure. Int. J Radiat. Oncol Biol. Phys. 23,261-270 (1992).
   Google Scholar
• •• Large series reviewing conventional radiotherapy.
   Google Scholar
• Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br. Radial 63,51–58 (1990).
   Google Scholar
• •Large series analyzing the prognostic factors of nasopharyngeal carcinoma.
   Google Scholar
• Qin DX, Hu YH, Yan JH et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 61, 1117–1124 (1988).
   PubMed Web of Science ®Google Scholar
• Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int. J Radiat. Oncol Biol. Ph). 30,1029-1036 (1994).
   Google Scholar
• •Large series analyzing the factors for tumor control with radiotherapy.
   Google Scholar
• International Nasopharynx Cancer Study Group. VUMCA I Trial: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV ( > N2, MO) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int. J Radiat. Oncol Biol. Phys. 35,463-469 (1996).
   Google Scholar
• Chua DTT, Sham JST, Choy D et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 83, 2270–2283 (1998).
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, LeBlanc M, Giri PG etal. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. Clin. Oncol 16,1310–1317 (1998).
   Google Scholar
• •Prospective randomized study showing that the addition of chemotherapy to radiotherapy for primary treatment of nasopharyngeal carcinoma has survival benefit.
   Google Scholar
• Tan EH, Chua ET, Wee J et al. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results. Int. J. Radiat. Oncol Biol. Phys. 45,597–601 (1999).
   PubMedGoogle Scholar
• Sham JST, Choy D, Wei WI, Yau CC. The value of clinical follow-up for local nasopharyngeal carcinoma relapse. Head Neck 14,208–217 (1992).
   PubMedGoogle Scholar
• Lo YM, Chan LY, Chan AT et al Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res. 59, 5452–5455 (1999).
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung SF, Chan LY et al. Kinetic of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res. 60,2351–2355 (2000).
   PubMedGoogle Scholar
• Teo P, Ho JHC, Choy D, Choi P, Tsui KH. Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma. int. J. Radiat. Oncol Biol. Phys. 13,679–685 (1987).
   Google Scholar
• Sham JS, Choy D. Nasopharyngeal carcinoma: treatment of neck node recurrence by radiotherapy. Austmlas Radial 35,370–373 (1991).
   PubMedGoogle Scholar
• Wei WI, Lam KH, Ho CM, Sham JST, Lau SK. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma. Am. J. Surg. 160,439–442 (1990).
   Google Scholar
• Wei WI, Ho CM, Wong MP, Ng WF, Lau SK, Lam KH. Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma. Arch. Otolaryngol Head Neck Surg: 118,923–929 (1992).
   PubMedGoogle Scholar
• •Whole specimen sectioning study documenting the extent of tumor involvement in the neck nodes to establish the basis for planning surgical salvage.
   Google Scholar
• Wei WI. Carcinoma of the nasopharynx. Adv. Otolaryngol Head Neck Surg. 12, 119–132 (1998).
   Google Scholar
• Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma —treatment techniques and results. Int. J. Radiat. Oncol Biol. Riyc. 13, 953–956 (1987).
   PubMed Web of Science ®Google Scholar
• Woo E, Lam K, Yu YL, Ma J, Wang C, Yeung RT. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: a distinct clinical syndrome. Neural Neurosurg. PTchiatry51, 1302–1307 (1988).
   PubMed Web of Science ®Google Scholar
• Lee AW, Law SC, Foo W et al Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence. Int. .1. Radiat. Oncol Bid Phys. 26, 773–782 (1988).
   Google Scholar
• Chua DT, Sham JST, Hung KN, LW Kwong D, Kwong PW, Leung LH. Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma. Head Neck21, 620–626 (1999).
   Google Scholar
• •Report of early experience in the application of stereotactic radiosurgery in the salvage of local disease.
   Google Scholar
• Wei WI, Sham JST, Choy D, Ho CM, Lam KH. Split-palate approach for gold grain implantation in nasopharyngeal carcinoma. Arch. Otolaryngol Head Neck Surg. 116, 578–582 (1990).
   PubMedGoogle Scholar
• Kwong DLW, Wei WI, Cheng ACK etal. Long-term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma. Cancer 91, 1105–1113 (2001).
   Google Scholar
• ••Large recent series reporting the long-term efficacy of brachytherapy in the menagement of local disease.
   Google Scholar
• Leung TW, Tung SY, Wong VY et al. High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma. Acta Oncol 35, 43–47 (1996).
   PubMed Web of Science ®Google Scholar
• Wei WI, Yuen APW, Ho WK. Surgical options for continuing treatment of recurrent nasopharyngeal carcinoma. Cum Opin. Otolaryngol Head Neck Surg. 8, 117–121 (2000).
   Google Scholar
• Wei WI, Lam KH, Sham JST. New approach to the nasopharynx: the maxillary swing approach. Head Neck 13, 200–207 (1991).
   PubMed Web of Science ®Google Scholar
• Wei WI, Ho CM, Yuen PW, Fung CF, Sham JST, Lam KH. Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch. Otolaryngol Head Neck Surg. 121, 638–642 (1995).
   PubMedGoogle Scholar
• Wei WI. Salvage surgery for recurrent primary nasopharyngeal carcinoma Grit. Rev. Oncold-lematol 33,91–98 (2000).
   PubMed Web of Science ®Google Scholar
• •Updated results of surgical salvage for recurrent primary nasopharyngeal carcinoma.
   Google Scholar
• Fandi A, Bachouchi M, Azli N etal. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. I Clin. Oiled 18, 1324–1330 (2000).
   Google Scholar
• Chua DT, Kwong DL, Sham JST, Au GK, Choy D. A Phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy. Eur. I Cancer 36, 736–741 (2000).
   Google Scholar
• •Use of chemotherapy in the treatment of recurrent nasopharyngeal carcinoma.
   Google Scholar
• Tan EH, Khoo KS, Wee J et al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann. Oncology 10, 235–237 (1999).
   PubMed Web of Science ®Google Scholar
• Cheng LC, Sham JST, Chiu CSW, Fu KH, Lee MT, Mok CK. Surgical resection of pulmonary metastases from nasopharyngeal carcinoma. Aust. NZ J. Surg. 66, 71–73 (1996).
   PubMedGoogle Scholar
• Ho WK, Wei WI, Kwong DLW etal. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. Head Neck 21, 547–553 (1999).
   PubMed Web of Science ®Google Scholar
• •Prospective study identifying one of the long-term complications following successful treatment.
   Google Scholar
• Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function — a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q. I Med 78, 165–176 (1991).
   Google Scholar
• Lee AW, Law SC, Ng SH et al. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. BE I Radial 65, 918–928 (1992).
   Google Scholar
• Sham JST, Choy D, Kwong PW et al Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio. Int. I Radiat. Oncol Biol. Phys. 29, 699–704 (1994).
   PubMedGoogle Scholar
• •Modification of radiotherapy technique to reduce side effects without sacrificing good patient outcome.
   Google Scholar
• Dickens P, Wei WI, Sham JST. Osteosarcoma of the maxilla in Hong Kong Chinese postirradiation for nasopharyngeal carcinoma. Cancer66, 1924–1928 (1990).
   Google Scholar